4.7 Article

Mutations of the Igβ gene cause agammaglobulinemia in man

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 204, Issue 9, Pages 2047-2051

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20070264

Keywords

-

Funding

  1. Telethon [GSP02476] Funding Source: Medline
  2. Fondazione Telethon Funding Source: Custom

Ask authors/readers for more resources

Agammaglobulinemia is a rare primary immunodeficiency characterized by an early block of B cell development in the bone marrow, resulting in the absence of peripheral B cells and low/ absent immunoglobulin serum levels. So far, mutations in Btk, mu heavy chain, surrogate light chain, Ig alpha, and B cell linker have been found in 85-90% of patients with agammaglobulinemia. We report on the first patient with agammaglobulinemia caused by a homozygous nonsense mutation in Ig beta, which is a transmembrane protein that associates with Ig alpha as part of the preBCR complex. Transfection experiments using Drosophila melanogaster S2 Schneider cells showed that the mutant Ig beta is no longer able to associate with Ig alpha, and that assembly of the BCR complex on the cell surface is abrogated. The essential role of Ig beta for human B cell development was further demonstrated by immunofluorescence analysis of the patient's bone marrow, which showed a complete block of B cell development at the pro-B to preB transition. These results indicate that mutations in Ig beta can cause agammaglobulinemia in man.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available